NCT01688193View on ClinicalTrials.gov

Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male

CompletedOBSERVATIONAL
Enrollment

68

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Rheumatoid Arthritis
Trial Locations (1)

Unknown

Seoul University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT01688193 - Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male | Biotech Hunter | Biotech Hunter